News

Jakarta, Indonesia – Vaksindo continues to strengthen its position as a research-based animal vaccine company by expanding its reach into the Eurasian market. This strategic move aligns with Indonesia’s national agenda to enhance industrial competitiveness and promote value-added exports. 

Through engagements with delegations from Russia, Armenia, Belarus, and Kyrgyzstan, Vaksindo is opening new opportunities for cross-border collaboration and long-term partnerships. These engagements mark a significant milestone, reflecting growing international trust in Vaksindo’s capabilities as a producer of high-quality animal vaccines that meet international standards. At the same time, this progress reinforces Indonesia’s position as an increasingly recognized player in the global animal health industry. 

“This momentum presents a strong opportunity for Vaksindo to expand exports to the Eurasian region, where demand for vaccines remains high while availability is still limited. We are optimistic about continuing to deliver innovative and high-quality animal health solutions,” said Teguh Y. Prajitno, President Director of Vaksindo. 

As global demand for animal health solutions continues to rise, Vaksindo remains committed to strengthening its production capacity, enhancing innovation capabilities, and expanding its distribution network. The Eurasian region represents a key strategic focus with significant growth potential. 

This expansion not only reinforces Vaksindo’s global positioning but also contributes to Indonesia’s export growth, in line with the government’s vision of building a competitive and resilient animal health industry. 

Looking ahead, Vaksindo is confident in its ability to play a greater role in the global animal health sector through sustainable growth, continuous innovation, and strong international partnerships.